EpiSonica’s MRgHIFU, ArcBlate 100M, offers non-invasive thermal ablation treatments for soft tissues of uterine fibroids, adenomyosis and palliation for painful bone metastases, etc. ArcBlate has received Taiwan FDA approval as Class III medical device and is under CE MDR reviewing. The first ArcBlate system has been installed at Dalin Tzu Chi Hospital (Taiwan) to provide a new treatment option for uterine fibroids and adenomyosis.
Advantages: - No Incision, No Bleeding, No Radiation - Low dose sedation, Patient is conscious during treatment - Minimizes complications, adverse events and recovery time - Improve patient's quality of life
Electromedical Equipment / Medical Technology | Medical Furniture and Equipment | Medical Consumables
